Real-World Outcomes of Metastasis-Directed Stereotactic Radiotherapy in Driver-Mutated Oligometastatic and Oligoprogressive Metastatic Lung Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e682
DOI: 10.1016/j.ijrobp.2026.06.2131 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von A. Gonzalez und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gonzalez, A., Pulido, E., Cardona, A., Rojas, L., Ávila-Rodríguez, V., Aya, A., Zuluaga, J., Gutiérrez-Babativa, L., Sanchez, N., Sierra, Y., Martínez, S., Viola, L., Carvajal, C., Vecchio, A. D., Cuevas, D., Rodríguez, A., Moraes, F., & Bobadilla, I. (2026). Real-World Outcomes of Metastasis-Directed Stereotactic Radiotherapy in Driver-Mutated Oligometastatic and Oligoprogressive Metastatic Lung Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), e682. https://doi.org/10.1016/j.ijrobp.2026.06.2131
Vancouver
Gonzalez A, Pulido E, Cardona A, Rojas L, Ávila-Rodríguez V, Aya A, et al. Real-World Outcomes of Metastasis-Directed Stereotactic Radiotherapy in Driver-Mutated Oligometastatic and Oligoprogressive Metastatic Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e682. doi:10.1016/j.ijrobp.2026.06.2131
BibTeX
@article{Gonzalez2026,
author = {Gonzalez, A. and Pulido, E. and Cardona, A. and Rojas, L. and Ávila-Rodríguez, V. and Aya, A.C. and Zuluaga, J. and Gutiérrez-Babativa, L. and Sanchez, N. and Sierra, Y.V. and Martínez, S. and Viola, L. and Carvajal, C. and Vecchio, A. del and Cuevas, D.M. and Rodríguez, A.P. and Moraes, F.Y.Y. and Bobadilla, I.},
title = {Real-World Outcomes of Metastasis-Directed Stereotactic Radiotherapy in Driver-Mutated Oligometastatic and Oligoprogressive Metastatic Lung Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e682},
doi = {10.1016/j.ijrobp.2026.06.2131}
}
EUVIMED